Loading stock…

AtaiBeckley Inc. (ATAI) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

AtaiBeckley Inc.

ATAIMarket cap $2.73BPrice $7.3

Country🇺🇸United States

SectorHealthcare

IndustryPharmaceuticals

Develops psychedelic-based therapies to treat depression, anxiety, and addiction—conditions that traditional antidepressants often fail to fix. Backed by biotech billionaire Christian Angermayer, it's betting mental health's next breakthrough won't come from a pill you take forever.

In Bastion Portfolios?

52W Return+39%

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+160%10

Revenue Forecast

Rev CAGR (1y)+39%9

Rev CAGR (3y)-13%1

Rev CAGR (5y)+93%10

Earnings Forecast

EPS Growth Y+1Loss1

EPS Growth Y+2Loss1

EPS Growth Y+3Loss1

Quality

Margins

EBIT Margin-3170%1

Net Income Margin-14942%1

Free Cash Flow Margin-2837%1

Debt

Net Debt/EBITDAna–

Efficiency

ROE-417%1

ROA-294%1

Earnings Stability88

GEAR+VERY WEAK5

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)na–

P/E Ratio (Forward 3y)na–

P/BV15.51

EV Multiples

EV/EBITDA Fwdna–

EV/EBIT Fwdna–

Yield

Free Cash Flow Yield-4.6%2

Dividend Yieldna–

Momentum

Short term

1 month return+1%8

3 month return+38%10

YTD return+80%10

Mid term

Price vs 52wHighna–

1 year return+35%8

Long term

3 year return+440%10

5 year return-41%2

Risk Shield

Price Risk

Beta1.04

Volatility77%1

Free Cash Flow

Free Cash Flow Margin-2837%1

Free Cash Flow Yield-4.6%2

Quality

ROCE-71%1

Earnings Stability88

Net Debt/EBITDAna–

02Growth

Is it actually growing, and how fast?

Revenue$B

Actual

Est

GROWTH RATING↗

AVERAGE49 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+160%10

Revenue, next 1Y+39%9

Revenue, next 3Y, CAGR-13%1

Revenue, next 5Y, CAGR+93%10

EARNINGS FORECAST▾SCORE

EPS growth, FY1ELoss1

EPS growth, FY+2Loss1

EPS growth, FY+3Loss1

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 160%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to shrink 13%/yr over the next 3 years, ahead of most of the market.7/10

The runway holds up: revenue is set to grow 93%/yr over five years.10/10

WATCH

A mid-pack grower, ahead of 49% of companies worldwide.

WEAKNESSES

Revenue grew 160%/yr over the last 3 years, but it is set to shrink 13%/yr from here.

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Top-Line Rocket

A middle-of-the-pack grower heading into decline. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE60 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+1%8

3-month return+38%10

YTD return+80%10

MID & LONG-TERM▾SCORE

% of 52-week highna–

1-year return+35%8

3-year return+440%10

5-year return-41%2

MOMENTUM ASSESSMENT

STRENGTHS

It's up 35% over the past year, but 100% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+1%), over three months (+38%) and so far this year (+80%).

WATCH

Average long-term results. Multi-year returns are middling (+440% over three years and -41% over five), roughly average for the market.

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on AtaiBeckley Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

Revenue$B

Actual

Est

GROWTH RATING↗

AVERAGE49 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+160%10

Revenue, next 1Y+39%9

Revenue, next 3Y, CAGR-13%1

Revenue, next 5Y, CAGR+93%10

EARNINGS FORECAST▾SCORE

EPS growth, FY1ELoss1

EPS growth, FY+2Loss1

EPS growth, FY+3Loss1

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 160%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to shrink 13%/yr over the next 3 years, ahead of most of the market.7/10

The runway holds up: revenue is set to grow 93%/yr over five years.10/10

WATCH

A mid-pack grower, ahead of 49% of companies worldwide.

WEAKNESSES

Revenue grew 160%/yr over the last 3 years, but it is set to shrink 13%/yr from here.

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Top-Line Rocket

A middle-of-the-pack grower heading into decline. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE60 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+1%8

3-month return+38%10

YTD return+80%10

MID & LONG-TERM▾SCORE

% of 52-week highna–

1-year return+35%8

3-year return+440%10

5-year return-41%2

MOMENTUM ASSESSMENT

STRENGTHS

It's up 35% over the past year, but 100% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+1%), over three months (+38%) and so far this year (+80%).

WATCH

Average long-term results. Multi-year returns are middling (+440% over three years and -41% over five), roughly average for the market.

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on AtaiBeckley Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community